Recombinant Human IDOL protein (His-DDDDK tag N-Terminus)
Be the first to review this product! Submit a review
|
(1 Publication)
Recombinant Human IDOL protein (His-DDDDK tag N-Terminus) is a Human Full Length protein, in the 2 to 445 aa range, expressed in Baculovirus infected Sf9 cells, with >89%, suitable for SDS-PAGE.
View Alternative Names
BZF1, IDOL, BM-023, PP5242, MYLIP, E3 ubiquitin-protein ligase MYLIP, Inducible degrader of the LDL-receptor, Myosin regulatory light chain interacting protein, RING-type E3 ubiquitin transferase MYLIP, Idol, MIR
- SDS-PAGE
Supplier Data
SDS-PAGE - Recombinant Human IDOL protein (His-DDDDK tag N-Terminus) (AB198638)
4-20% SDS-PAGE with Coomassie staining
Lane 1 : 0.9 μg ab198638
Lane 2 : Protein marker
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Within cellular systems IDOL regulates cholesterol homeostasis by controlling the degradation of LDL receptors. It is not directly part of a large protein complex but interacts with other proteins involved in lipid metabolism. By mediating LDLR degradation IDOL indirectly affects cholesterol uptake by cells. IDOL's regulatory mechanism is vital in preventing excessive cellular cholesterol accumulation which can lead to various metabolic problems if unregulated.
Pathways
IDOL serves an important role in the lipid metabolic pathways and is part of the broader cholesterol efflux regulatory network. IDOL acts downstream of the Liver X Receptor (LXR) pathway. The LXR upon activation by oxysterols promotes IDOL expression leading to enhanced LDL receptor degradation. This pathway makes IDOL an important regulator of cholesterol levels linking it with proteins like LDLR and the LXRs. In this regulatory network IDOL ensures balanced cholesterol levels by modulating receptor availability and cholesterol uptake in the liver and peripheral tissues.
Specifications
Form
Liquid
Additional notes
Affinity purified.
General info
Function
E3 ubiquitin-protein ligase that mediates ubiquitination and subsequent proteasomal degradation of myosin regulatory light chain (MRLC), LDLR, VLDLR and LRP8. Activity depends on E2 enzymes of the UBE2D family. Proteasomal degradation of MRLC leads to inhibit neurite outgrowth in presence of NGF by counteracting the stabilization of MRLC by saposin-like protein (CNPY2/MSAP) and reducing CNPY2-stimulated neurite outgrowth. Acts as a sterol-dependent inhibitor of cellular cholesterol uptake by mediating ubiquitination and subsequent degradation of LDLR.
Post-translational modifications
Autoubiquitinated.
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Endocrine connections 11: PubMed35560019
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com